James R. Tobin, Director at TransMedics Group, Inc. (TMDX), sold 24,050 shares at $125.26 ($3.0M) on 2024-05-03, disclosed to the SEC on 2024-05-07.
Scheduled sale ($3.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $124.76 | 5,130 | $640K | 21.3% |
| 2 | $124.76 | 5,130 | $640K | 21.3% |
| 3 | $125.26 | 6,895 | $864K | 28.7% |
| 4 | $125.26 | 6,895 | $864K | 28.7% |
| Total | $125.05 avg | 24,050 | $3.0M | 100% |
| Filing → |
| TMDX | SELL | 2024-03-05 | $2.2M | — | Filing → |
| TMDX | SELL | 2023-11-29 | $701K | — | Filing → |
| TMDX | SELL | 2023-02-27 | $751K | — | Filing → |